基于Th1极化MtrE的淋病球菌疫苗显示了预防和治疗疗效
Shuaijie Song1, Shuyi Wang1, Xiaoyun Jiang1
1Department of Microbiology, and Department of Dermatology of Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
Emerging microbes & infections
|August 16, 2023
概括
开发一种针对耐药性淋病的疫苗至关重要. 这项研究表明,MtrE和Loop2抗原,与Th1极化辅助剂一起,即使在已确定的感染中,也能有效地对抗抗素耐药的尼塞利亚淋病菌.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 高水平的抗塞夫特里亚克松耐药性菌株,特别是FC428克隆,威胁着目前的治疗疗效.
- 疫苗接种是控制淋病等多抗药性感染的关键策略.
研究的目的:
- 评估MtrE及其表面Loop2作为潜在的疫苗抗原对*尼塞利亚淋病*.
- 为了确定一个最佳的Th1-极化辅助剂,以提高球菌疫苗的疗效.
主要方法:
- 实验室树突细胞成熟和T细胞分化试验被用于选辅助剂.
- CpG1826被确定为MtrE和Loop2抗原 (Nloop2,Intraloop2) 的最佳Th1极化辅助剂.
- 疫苗的有效性在小鼠阴道感染模型中进行了评估,评估了预防性和治疗性管理.
主要成果:
- 用CpG1826配制的基于循环2的抗原在小鼠中诱导了强大的Th1极化和杀菌性抗体反应.
- 疫苗配方在预防性地使用时,证明了对球菌挑战的保护.
- 一次治疗剂量加速了已确定的淋病的清除,包括对FC428克隆菌株的清除.
结论:
- MtrE和Loop2是有效的炎球菌疫苗抗原.
- Th1极化辅助剂CpG1826增强了对*尼塞利亚淋病*的免疫反应.
- 这些发现支持开发用于预防和治疗淋病的基于MtrE和Loop2的疫苗.
关键词:
在CpG182626中使用.FC42828 FC428 是一个关于在MtrEE中使用.尼塞里亚淋病菌 (Neisseria gonorrhoeae) 是一种传染病.Th1 两极分化的情况.疫苗 疫苗 疫苗 疫苗更多相关视频
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
1.8K
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
8.6K
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
54
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
54
01:30Cancer Vaccines
403
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
403